Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Stage II Bladder Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Not Yet RecruitingNCT07793318
What this trial is testing

TR115 in ARID1A-Mutated Advanced Solid Tumors

Who this might be right for
Ovarian Clear Cell CarcinomaEndometrial CancerStomach Cancer Recurrent+1 more
Tarapeutics Science Inc. 50
Testing effectiveness (Phase 2)Study completedNCT01520038
What this trial is testing

Adjuvant Proton Therapy or IMRT for the Treatment of Bladder Cancer

Who this might be right for
Urothelial Carcinoma of the Bladder
Abramson Cancer Center at Penn Medicine 2
Testing effectiveness (Phase 2)Active Not RecruitingNCT03601455
What this trial is testing

Radiation Therapy and Durvalumab With or Without Tremelimumab in Treating Participants With Unresectable, Locally Advanced, or Metastatic Bladder Cancer

Who this might be right for
Bladder Urothelial CarcinomaStage IV Bladder Cancer AJCC v8Stage IVA Bladder Cancer AJCC v8+1 more
Jonsson Comprehensive Cancer Center 13
Testing effectiveness (Phase 2)Ended earlyNCT01374789
What this trial is testing

PURO Panitumumab in Combination With Gemcitabine/Cisplatin in Advanced Urothelial Cancer

Who this might be right for
Urinary Bladder Cancer
WiSP Wissenschaftlicher Service Pharma GmbH 2
Testing effectiveness (Phase 2)Ended earlyNCT02887248
What this trial is testing

Nab-paclitaxel Plus Gemcitabine as First-line Therapy for Cisplatin-ineligible or Cisplatin-incurable Advanced Urothelial Carcinoma

Who this might be right for
Urothelial CarcinomaBladder CancerTransitional Cell Carcinoma
SCRI Development Innovations, LLC 3
Testing effectiveness (Phase 2)Ended earlyNCT04047693
What this trial is testing

Neoadjuvant Dose Dense MVAC in MIBC and Locally Advanced Urothelial Carcinoma

Who this might be right for
Muscle Invasive Bladder CancerUrothelial CarcinomaNeoadjuvant Chemotherapy
Pusan National University Yangsan Hospital 24
Testing effectiveness (Phase 2)Study completedNCT00192049
What this trial is testing

Study Comparing Single Agent Gemcitabine Intravesical Therapy Versus Mitomycin C in Patients With Intermediate Risk Superficial Bladder Cancer

Who this might be right for
Superficial Bladder Cancer
Eli Lilly and Company 90
Testing effectiveness (Phase 2)Study completedNCT01489813
What this trial is testing

Study of Genistein in Reducing Side Effects of Superficial Bladder Cancer Treatment

Who this might be right for
Bladder Cancer
Emory University 36
Testing effectiveness (Phase 2)Study completedNCT02581982
What this trial is testing

Paclitaxel and Pembrolizumab in Treating Patients With Refractory Metastatic Urothelial Cancer

Who this might be right for
Transitional Cell Carcinoma
Wake Forest University Health Sciences 27
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07279597
What this trial is testing

A Phase II Study of Toripalimab Plus RC48-ADC With Radiotherapy for Bladder Preservation in HER2-Positive Muscle-Invasive Bladder Cancer

Who this might be right for
Muscle-invasive Bladder Urothelial Carcinoma
Tongji Hospital 45
Testing effectiveness (Phase 2)Study completedNCT00556621
What this trial is testing

Gemcitabine, Cisplatin, and Radiation Therapy in Treating Patients With Stage II or Stage III Bladder Cancer

Who this might be right for
Bladder Cancer
Institut du Cancer de Montpellier - Val d'Aurelle 14
Testing effectiveness (Phase 2)Looking for participantsNCT06161532
What this trial is testing

Sacituzumab Govitecan With or Without Atezolizumab Immunotherapy in Rare Genitourinary Tumors (SMART) Such as High Grade Neuroendocrine Carcinomas, Adenocarcinoma, and Squamous Cell Bladder/Urinary Tract Cancer, Renal Medullary Carcinoma and Penile C...

Who this might be right for
Small Cell Carcinoma of the BladderSmall Cell Carcinoma of the Urinary TractSquamous Cell Carcinoma of the Bladder+5 more
National Cancer Institute (NCI)
Testing effectiveness (Phase 2)Study completedNCT02459119
What this trial is testing

Study of Regorafenib for Urothelial Cancer Following Chemotherapy (UAB 1477)

Who this might be right for
Urothelial Cancer (Urinary Bladder, Ureters, or Renal Pelvis Cancer)
University of Alabama at Birmingham 17
Testing effectiveness (Phase 2)Study completedNCT00003175
What this trial is testing

Fluorouracil in Treating Patients With Recurrent or Metastatic Bladder Cancer

Who this might be right for
Bladder CancerTransitional Cell Cancer of the Renal Pelvis and UreterUrethral Cancer
Medical Research Council 45
Testing effectiveness (Phase 2)UnknownNCT04813107
What this trial is testing

Evaluate the Safety and Efficacy of Oral APL-1202 in Combination With Tislelizumab Compared to Tislelizumab Alone as Neoadjuvant Therapy in Patients With Muscle Invasive Bladder Cancer

Who this might be right for
Muscle Invasive Bladder Cancer
Jiangsu Yahong Meditech Co., Ltd aka Asieris 79
Not applicableLooking for participantsNCT06679920
What this trial is testing

Study With a Newly Optical Coherence Tomography Probe for Optimizing Bladder Cancer Diagnosis and Treatment

Who this might be right for
Bladder Cancer
Amsterdam UMC 15
Not applicableStudy completedNCT06768346
What this trial is testing

Hyperthermic Intra-Vesical Chemotherapy

Who this might be right for
Bladder Cancer
Queen Mary University of London 259
Not applicableStudy completedNCT00539773
What this trial is testing

Phase II Trial of Concurrent Administration of Intravesical BCG & Interferon in the Treatment and Prevention of Recurrence of Superficial Transitional Carcinoma of the Urinary Bladder

Who this might be right for
Transitional Carcinoma of Urinary Bladder
King Faisal Specialist Hospital & Research Center 10
Early research (Phase 1)Study completedNCT00020579
What this trial is testing

MS-275 in Treating Patients With Advanced Solid Tumors or Lymphoma

Who this might be right for
Cancer
National Institutes of Health Clinical Center (CC) 75
Testing effectiveness (Phase 2)Study completedNCT00948961
What this trial is testing

CDX-1401 in Patients With Malignancies Known to Express NY-ESO-1

Who this might be right for
Advanced Malignancies
Celldex Therapeutics 70
Next Page
60